Trazium esilate (EGYT-3615) is an antidepressant that modulates the central dopaminergic system; it exhibits synergistic effects with amphetamine to enhance stereotypic behavior and hyperlocomotion; it antagonizes apomorphine-induced hypothermia and stereotypy, as well as bulbocapnine-induced catalepsy; it potentiates the effect of norepinephrine on isolated rat vas deferens.